TuisSHTDY • OTCMKTS
add
Sinopharm Group ADR
Vorige sluiting
$13,45
Dagwisseling
$13,16 - $13,86
Jaarwisseling
$10,84 - $14,87
Markkapitalisasie
65,28 mjd HKD
Gemiddelde volume
75,94 k
P/V-verhouding
-
Dividend-opbrengs
-
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 143,69 mjd | 1,13% |
Bedryfskoste | 5,00 mjd | -10,42% |
Netto inkomste | 1,85 mjd | 4,36% |
Netto winsgrens | 1,29 | 3,20% |
Wins per aandeel | — | — |
EBITDA | 5,97 mjd | -2,51% |
Effektiewe belastingkoers | 30,30% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 48,80 mjd | -10,16% |
Totale bates | 390,36 mjd | -0,63% |
Totale aanspreeklikheid | 256,20 mjd | -3,74% |
Totale ekwiteit | 134,16 mjd | — |
Uitstaande aandele | 3,12 mjd | — |
Prys om te bespreek | 0,50 | — |
Opbrengs op bates | 3,34% | — |
Opbrengs op kapitaal | 6,42% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 1,85 mjd | 4,36% |
Kontant van bedrywe | 53,22 mjd | -10,21% |
Kontant van beleggings | -1,21 mjd | 67,09% |
Kontant van finansiering | -30,23 mjd | 18,95% |
Netto kontantverandering | 21,77 mjd | 19,12% |
Beskikbare kontantvloei | 24,05 mjd | — |
Meer oor
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Gestig
2003
Webwerf
Werknemers
94 910
